Home/Filings/4/0001567619-22-013867
4//SEC Filing

Beigelman Leonid 4

Accession 0001567619-22-013867

CIK 0001799448other

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 4:13 PM ET

Size

5.7 KB

Accession

0001567619-22-013867

Insider Transaction Report

Form 4
Period: 2022-07-07
Beigelman Leonid
DirectorPresident
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-07+113,000113,000 total
    Exercise: $1.41Exp: 2032-07-07Common Stock (113,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from July 7, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1
  • filerCIK 0001824721

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:13 PM ET
Size
5.7 KB